Psychiatry investigation

Korean Neuropsychiatric Association (대한신경정신의학회)
권호 표지
DOI QR코드

DOI QR Code

Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Is a Risk Factor for Attention-Deficit Hyperactivity Disorder in a Turkish Sample

  • Ozturk, Onder (Child and Adolescent Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Basay, Burge Kabukcu (Child and Adolescent Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Buber, Ahmet (Child and Adolescent Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Basay, Omer (Child and Adolescent Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Alacam, Huseyin (Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Bacanli, Ali (Child and Adolescent Psychiatry Polyclinic, Children Hospital) ;
  • Yilmaz, Senay Gorucu (Department of Nutritions and Dietetics, Faculty of Healthy Science, University of Gaziantep) ;
  • Erdal, Mehmet Emin (Medical Biology and Genetics Department, Mersin University Medical Faculty) ;
  • Herken, Hasan (Psychiatry Department, Pamukkale University Medical Faculty) ;
  • Ercan, Eyup Sabri (Child and Adolescent Psychiatry Department, Ege University Medical Faculty)
  • Received : 2015.08.25
  • Accepted : 2015.12.30
  • Published : 2016.09.25
⟨ Previous Next ⟩

Abstract

Objective Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that negatively affects different areas of life. We aimed to evaluate the associations between the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) and ADHD and to assess the effect of the BDNF polymorphism on the neurocognitive profile and clinical symptomatology in ADHD. Methods Two hundred one ADHD cases and 99 typically developing subjects (TD) between the ages of 8 and 15 years were involved in the study. All subjects were evaluated using a complete neuropsychological battery, Child Behavior Checklist, the Teacher's Report Form (TRF) and the DSM-IV Disruptive Behavior Disorders Rating Scale-teacher and parent forms. Results The GG genotype was significantly more frequent in the patients with ADHD than in the TD controls, and the GG genotype was also significantly more frequent in the ADHD-combined (ADHD-C) subtype patients than in the TDs. However, there were no significant associations of the BDNF polymorphism with the ADHD subtypes or neurocognitive profiles of the patients. The teacher-assessed hyperactivity and inattention symptom count and the total score were higher, and the appropriately behaving subtest score of the TRF was lower in the GG genotypes than in the GA and AA (i.e., the A-containing) genotypes. Conclusion We found a positive association between the BDNF gene Val66Met polymorphism and ADHD, and this association was observed specifically in the ADHD-C subtype and not the ADHD-predominantly inattentive subtype. Our findings support that the Val66Met polymorphism of BDNF gene might be involved in the pathogenesis of ADHD. Furthermore Val66Met polymorphism of BDNF gene may be more closely associated with hyperactivity rather than inattention.

Keywords

References

  1. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-248. https://doi.org/10.1016/S0140-6736(05)66915-2
  2. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313-1323. https://doi.org/10.1016/j.biopsych.2004.11.024
  3. Banaschewski T, Becker K, Scherag S, Franke B, Coghill D. Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 2010;19:237-257. https://doi.org/10.1007/s00787-010-0090-z
  4. Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000;36:197-202. https://doi.org/10.1016/S0197-0186(99)00122-9
  5. Carvalho A, Caldeira M, Santos S, Duarte C. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol 2008;153 (Suppl 1):310-324.
  6. Traver S, Marien M, Martin E, Hirsch EC, Michel PP. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway. Mol Pharmacol 2006;70:30-40.
  7. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001;411:86-89. https://doi.org/10.1038/35075076
  8. Chen SL, Lee SY, Chang YH, Wang TY, Chen SH, Chu CH, et al. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients. Sci Rep 2015;2:8148.
  9. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999;22:231-238. https://doi.org/10.1038/10290
  10. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006;314:140-143. https://doi.org/10.1126/science.1129663
  11. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66-Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004;161:1698-1700. https://doi.org/10.1176/appi.ajp.161.9.1698
  12. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005;10:208-212. https://doi.org/10.1038/sj.mp.4001575
  13. Ribases M, Gratacos M, Armengol L, de Cid R, Badia A, Jimenez L, et al. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 2003;8:745-751. https://doi.org/10.1038/sj.mp.4001281
  14. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A, et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003;28:397-401. https://doi.org/10.1038/sj.npp.1300053
  15. Lanktree M, Muglia P, Squassina A, Krinsky M, Jain U, Macciadi F, et al. A potential role for brain derived neurotrophic factor (BDNF) in adult ADHD. Abstract in Am J Med Gent Part B 2004;130B:96-97.
  16. Kent L, Green E, Hawi Z, Kirley A, Dudbridge F, Lowe N, et al. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brainderived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry 2005;10:939-943. https://doi.org/10.1038/sj.mp.4001696
  17. Friedel S, Fontenla Horro F, Wermter AK, Geller F, Dempfle A, Reichwald K, et al. Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders and attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2005;132B:96-99. https://doi.org/10.1002/ajmg.b.30090
  18. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 2006;11:934-953. https://doi.org/10.1038/sj.mp.4001869
  19. Lee YH, Song GG. BDNF 196 G/A and COMT Val158Met polymorphisms and susceptibility to ADHD: a meta-analysis. J Atten Disord [Epub ahead of print].
  20. Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 2004;18:485-503. https://doi.org/10.1037/0894-4105.18.3.485
  21. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A metaanalysis of working memory impairments in children with attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2005;44:377-384. https://doi.org/10.1097/01.chi.0000153228.72591.73
  22. Lee J, Laurin N, Crosbie J, Ickowicz A, Pathare T, Malone M, et al. Association study of the brain derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2007;5:976-981.
  23. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001;15:1748-1757. https://doi.org/10.1210/mend.15.10.0706
  24. Kiprianova I, Sandkuhler J, Schwab S, Hoyer S, Spranger M. Brain derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp Neurol 1999;159:511-519. https://doi.org/10.1006/exnr.1999.7109
  25. Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 2000;20:7116-7121. https://doi.org/10.1523/JNEUROSCI.20-18-07116.2000
  26. Achenbach TM. Integrative Guide for the CBCL/4-18, YSR, and TRF Profiles. Burlington: Department of Psychiatry, University of Vermont; 1991.
  27. Ercan ES, Amado S, Somer O, Cikoglu S. [Development of a test battery for the assessment of attention deficit hyperactivity disorder]. Turk J Child Adoles Ment Health 2001;8:132-144.
  28. Gokler B, Unal F, Pehlivanturk B, Kultur EC, Akdemir D, Taner Y. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (KSADS-PL-T). Turk J Child Adolesc Ment Health 2004;11:109-116.
  29. Leckman JF, Sholomskas D, Thompson D, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982;39:879-883. https://doi.org/10.1001/archpsyc.1982.04290080001001
  30. Gualtieri CT, Johnson LG. Age-related cognitive decline in patients with mood disorders. Prog Neuro Psychopharmacol Biol Psychiatry 2008;32:962-967. https://doi.org/10.1016/j.pnpbp.2007.12.030
  31. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-736. https://doi.org/10.1146/annurev.neuro.24.1.677
  32. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brainderived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561. https://doi.org/10.1016/S0028-3908(98)00141-5
  33. Ozan E, Okur H, Eker c, Eker OD, Gonul AS, Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 2010;81:61-65. https://doi.org/10.1016/j.brainresbull.2009.06.022
  34. Zhang XY, Chen da C, Xiu MH, Haile CN, Luo X, Xu K, et al. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Human Genet 2012;131:1187-1195. https://doi.org/10.1007/s00439-012-1150-x
  35. Lang UE, Hellweg R, Sander T, Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 2009;14:120-122. https://doi.org/10.1038/mp.2008.80
  36. Bus BA, Arias-Vasquez A, Franke B, Prickaerts J, de Graaf J, Voshaar RC. Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males. Neuropsychobiology 2012;65:183-187. https://doi.org/10.1159/000336997
  37. Aureli A, Del Beato T, Sebastiani P, Marimpietri A, Melillo CV, Sechi E, et al. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. Int J Immunopathol Pharmacol 2010;23:873-880. https://doi.org/10.1177/039463201002300323
  38. Li H, Liu L, Tang Y, Ji N, Yang L, Qian Q, et al. Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naive Han Chinese sample. Psychiatry Res 2014;30;217:191-197. https://doi.org/10.1016/j.psychres.2014.03.011
  39. Schimmelmann BG, Friedel S, Dempfle A, Warnke A, Lesch KP, Walitza S, et al. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene [BDNF] in ADHD. J Neural Transm (Vienna) 2007;114:523-526. https://doi.org/10.1007/s00702-006-0616-1
  40. Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, Bosch R, Boreatti-Hummer A, et al. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 2010;153B:512-523. https://doi.org/10.1002/ajmg.b.31008
  41. Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E. Association of COMT (Val158Met) and BDNF (Val66Met) Gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder. J Autism Dev Disord 2009;39:1542-1551. https://doi.org/10.1007/s10803-009-0794-4
  42. Bergman O, Westberg L, Lichtenstein P, Eriksson E, Larsson H. Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity. Int J Neuropsychopharmacol 2011;14:1367-1376. https://doi.org/10.1017/S1461145711000502
  43. Willoughby MT. Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations. J Child Psychol Psychiatry 2003;44:88-106. https://doi.org/10.1111/1469-7610.t01-1-00104
  44. Egan M, Kojima M, Callicott J, Goldberg T, Kolachana B, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269. https://doi.org/10.1016/S0092-8674(03)00035-7
  45. Foltynie T, Lewis SGJ, Goldberg TE, Blackwell AD, Kolachana BS, Weinberger DR, et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol 2005;252:833-838. https://doi.org/10.1007/s00415-005-0756-5
  46. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003;5:468-472. https://doi.org/10.1046/j.1399-5618.2003.00071.x
  47. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory related hippocampal activity and predicts memory performance. J Neurosci 2003;23:6690-6694. https://doi.org/10.1523/JNEUROSCI.23-17-06690.2003
  48. Hashimoto R, Moriguchi Y, Yamashita F, Mori T, Nemoto K, Okada T, et al. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res 2008;61:360-367. https://doi.org/10.1016/j.neures.2008.04.003
  49. Dennis Na, Cabeza R, Need AC, Waters-Metenier S, Goldstein DB, Labar KS. Brain-derived neurotrophic factor val66met polymorphism and hippocampal activity on during episodic encoding and retrieval tasks. Hippocampus 2010;21:980-989.
  50. van Wingen G, Rijpkema M, Franke B, vanEijndhoven P, Tendolkar I, Verkes RJ, et al. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli. Neuroimage 2010;50:1212-1218. https://doi.org/10.1016/j.neuroimage.2010.01.058

Cited by

  1. ADHD: Reviewing the Causes and Evaluating Solutions vol.11, pp.3, 2016, https://doi.org/10.3390/jpm11030166